Get started
Author

Aine Maire De Bhailis

Observed names: Aine De Bhailis, Aine M. de Bhailis, Aine Maire DeBhailis, Aine de Bhailis, De Bhailis, Aine, De Bhailis, Áine, Á., DeBhailís, Áine De Bhailís, Áine DeBhailis, Áine M De Bhailis, Áine M De Bhailís, Áine M. de Bhailis, Áine M. de Bhailís, Áine de Bhailis, Áine deBhailís
Observed institutions: Royal College of Surgeons in Ireland, Trinity College Dublin, Salford Royal NHS Foundation Trust, Beaumont Hospital, Tallaght University Hospital, University of Manchester, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust
ORCID: 0000-0002-6223-5601
Observed ORCID: 0000-0002-6223-5601
OpenAlex ID: A5043346182
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
2023 · Brad H Rovin, Jonathan Barratt, et al. · The Lancet · 365
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
2023 · Hiddo J L Heerspink, Jai Radhakrishnan, et al. · The Lancet · 244
PDF
Hypertension and the kidneys
2022 · Áine M De Bhailis, Philip A Kalra · British Journal of Hospital Medicine · 137
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference
2021 · Caitlin W. Hicks, Timothy W.I. Clark, et al. · American Journal of Kidney Diseases · 85
Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies
2019 · Aisling Ui Mhaonaigh, Alice M. Coughlan, et al. · Frontiers in Immunology · 71
PDF
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2021 · Kirsten L. Johansen, Pranav S. Garimella, et al. · Kidney International · 68
Inflammation and Oxidative Damage in Ischaemic Renal Disease
2021 · Áine M. de Bhailís, Constantina Chrysochou, et al. · Antioxidants · 19
PDF
Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes
2021 · Áine M. de Bhailís, Shazli Azmi, et al. · Therapeutic Advances in Endocrinology and Metabolism · 19
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL Trial
2024 · Hannah O’Keeffe, Darren Green, et al. · Circulation Cardiovascular Interventions · 17
Managing acute presentations of atheromatous renal artery stenosis
2022 · Áine de Bhailis, Saif Al-Chalabi, et al. · BMC Nephrology · 13
PDF
Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi-disciplinary review
2024 · Áine M. de Bhailis, Edward Lake, et al. · Journal of Nephrology · 11
PDF
Cancer survival in kidney transplant recipients in Ireland
2020 · Susan L Murray, Eamonn O’Leary, et al. · Nephrology Dialysis Transplantation · 10
Pancreatitis associated with calciphylaxis successfully treated with sodium thiosulfate
2018 · Aoibheann Flynn, Aine de Bhailis, et al. · JAAD Case Reports · 4
Shifting Sands or ANCA-ed in Place? The Epidemiology of ANCA-Associated Vasculitis over 2 Decades at a Large Tertiary Centre
2025 · Joshua Storrar, Sawangchit Launiyomchon, et al. · Glomerular Diseases · 2
PDF
Insights From the UK on Fibromuscular Dysplasia in Pregnancy
2025 · Sharmilee Rengarajan, Henry H.L. Wu, et al. · Kidney International Reports · 1
PDF
Managing positive anti-glomerular basement membrane antibodies in the absence of disease
2026 · John Samuel Fulton, Grahame Wood, et al. · BMJ Case Reports
Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Real-World Insights from a Propensity Score Weighted Retrospective Cohort Study
2026 · William R. Marshall, Rajkumar Chinnadurai, et al. · American Journal of Nephrology
PDF
Supplementary Material for: Tolvaptan for autosomal dominant polycystic kidney disease: Real-world insights from a propensity score weighted retrospective cohort study
2026 · karger, figshare admin, W.R., Marshall, et al. · Figshare
Follow-up Outcomes from the first National Fibromuscular Dysplasia Clinic in the United Kingdom
2025 · Avanti Damle, Sharmilee Rengarajan, et al. · Journal of Hypertension
Correction to: Improving outcomes in atherosclerotic renovascular disease: importance of clinical presentation and multi‑disciplinary review
2024 · Áine M. de Bhailis, Edward Lake, et al. · Journal of Nephrology
Renovascular Disease: Updated Management Protocols
2024 · Philip A. Kalra, Áine DeBhailis, et al. · Springer eBooks
Renovascular Disease: improving outcomes in atherosclerotic disease and new initiatives in fibromuscular dysplasia.
2023 · De Bhailis, Áine · Research Explorer (The University of Manchester)
P0163epidemiology of Fmd: a Review of the Salford Experience
2020 · Aine De Bhailis, Tina Chrysochou · Nephrology Dialysis Transplantation
PDF
Caliphylaxis causes recurrent pancreatitis
2019 · Aoibheann Flynn, Aine de Bhailis, et al. · JAAD Case Reports
PDF
Works count: 25
Citation count: 1,066
H-index: 11
I10-index: 12
Year
Topic
Type